Cargando…
Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients
Cancer patients frequently exhibit a deficiency in Type-1 (but not Type-2 or regulatory) CD4(+) T cell responses against tumor-associated antigens (TAA), which may limit protection against disease progression or responsiveness to immunotherapy in these individuals. Since such deficiency was acutely...
Autores principales: | Wesa, Amy K., Mandic, Maja, Taylor, Jennifer L., Moschos, Stergios, Kirkwood, John M., Kwok, William W., Finke, James Harold, Storkus, Walter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178427/ https://www.ncbi.nlm.nih.gov/pubmed/25325015 http://dx.doi.org/10.3389/fonc.2014.00266 |
Ejemplares similares
-
Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand
por: Wesa, Amy, et al.
Publicado: (2002) -
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
por: Zhou, Cheng, et al.
Publicado: (2022) -
Pro- and anti-apoptotic CD95 signaling in T cells
por: Paulsen, Maren, et al.
Publicado: (2011) -
Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022) -
Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs
por: Guo, Wei, et al.
Publicado: (2021)